Hydroxychloroquine and COVID-19: a tale of populism and obscurantism.
作者信息
Peiffer-Smadja Nathan, Rebeaud Mathieu E, Guihur Anthony, Mahamat-Saleh Yahya, Fiolet Thibault
机构信息
Université de Paris, INSERM, IAME, F-75006 Paris, France; National Institute for Health Research Health Protection Research Unit in Healthcare Associated Infections and Antimicrobial Resistance, Imperial College London, London, UK; Infectious and Tropical Diseases Department, Bichat-Claude Bernard Hospital, AP-HP, Paris, France.
Department of Plant Molecular Biology, Faculty of Biology and Medicine, University of Lausanne, Switzerland.
出版信息
Lancet Infect Dis. 2021 May;21(5):e121. doi: 10.1016/S1473-3099(20)30866-5. Epub 2020 Nov 13.
Abstract
摘要
相似文献
1
Hydroxychloroquine and COVID-19: a tale of populism and obscurantism.羟氯喹与2019冠状病毒病：一个民粹主义与蒙昧主义的故事。
Lancet Infect Dis. 2021 May;21(5):e121. doi: 10.1016/S1473-3099(20)30866-5. Epub 2020 Nov 13.
2
The Rise and Fall of Hydroxychloroquine and Chloroquine in COVID-19.羟氯喹和氯喹在 COVID-19 中的兴衰。
J Pharm Pract. 2022 Dec;35(6):971-978. doi: 10.1177/0897190021997399. Epub 2021 Apr 28.
3
Ototoxicity prevention during the SARS-CoV-2 (COVID-19) emergency.在 SARS-CoV-2（COVID-19）紧急情况下预防耳毒性。
J Glob Antimicrob Resist. 2020 Dec;23:263-264. doi: 10.1016/j.jgar.2020.09.030. Epub 2020 Oct 17.
4
Chloroquine and hydroxychloroquine to treat COVID-19: between hope and caution.氯喹和羟氯喹治疗新型冠状病毒肺炎：希望与谨慎并存
Clin Toxicol (Phila). 2021 Jan;59(1):70-71. doi: 10.1080/15563650.2020.1748194. Epub 2020 Apr 2.
5
Response to: Efficacy and safety of hydroxychloroquine/chloroquine against SARS-CoV-2 infection: A systematic review and meta-analysis.回复：羟氯喹/氯喹治疗新型冠状病毒2感染的疗效与安全性：一项系统评价与荟萃分析
J Infect Chemother. 2021 Sep;27(9):1373-1374. doi: 10.1016/j.jiac.2021.05.020. Epub 2021 Jun 4.
6
Efficacy and safety of hydroxychloroquine/chloroquine against SARS-CoV-2 infection: A systematic review and meta-analysis - Authors reply.羟氯喹啉/氯喹啉治疗新型冠状病毒肺炎的疗效与安全性：一项系统评价与荟萃分析——作者回复
J Infect Chemother. 2021 Oct;27(10):1539-1540. doi: 10.1016/j.jiac.2021.07.010. Epub 2021 Jul 16.
7
Emergency Authorization of Chloroquine and Hydroxychloroquine for Treatment of COVID-19.氯喹和羟氯喹治疗 COVID-19 的紧急授权。
Ann Pharmacother. 2020 Aug;54(8):827-831. doi: 10.1177/1060028020925558. Epub 2020 May 9.
8
Reported Adverse Drug Reactions Associated With the Use of Hydroxychloroquine and Chloroquine During the COVID-19 Pandemic.新型冠状病毒肺炎大流行期间与使用羟氯喹和氯喹相关的药物不良反应报告
Ann Intern Med. 2021 Jun;174(6):878-880. doi: 10.7326/M20-7918. Epub 2021 Jan 26.
9
What makes (hydroxy)chloroquine ineffective against COVID-19: insights from cell biology.（羟）氯喹对抗 COVID-19 无效的原因：细胞生物学的见解。
J Mol Cell Biol. 2021 Jul 6;13(3):175-184. doi: 10.1093/jmcb/mjab016.
10
Hydroxychloroquine and Chloroquine.羟氯喹啉和氯喹啉。
Clin Infect Dis. 2020 Jul 28;71(15):890-891. doi: 10.1093/cid/ciaa338.
引用本文的文献
1
A Highway for Disinformation? The Alarming Exodus of Scientists from Twitter/X and its Consequences.一条虚假信息的高速公路？科学家们从推特/X平台令人震惊的大量流失及其后果。
Stem Cell Rev Rep. 2025 May;21(4):1127-1130. doi: 10.1007/s12015-025-10864-1. Epub 2025 Mar 13.
2
Safety and efficacy of favipiravir in COVID-19 patients with pneumonia. A randomized, double-blind, placebo-controlled study (FAVID).法匹拉韦在新冠肺炎肺炎患者中的安全性和有效性。一项随机、双盲、安慰剂对照研究（FAVID）。
Pneumonia (Nathan). 2024 Feb 25;16(1):3. doi: 10.1186/s41479-023-00124-6.
3
Application of the PHENotype SIMulator for rapid identification of potential candidates in effective COVID-19 drug repurposing.PHENotype模拟器在快速识别新冠病毒有效药物重新利用潜在候选药物中的应用。
Heliyon. 2023 Mar;9(3):e14115. doi: 10.1016/j.heliyon.2023.e14115. Epub 2023 Mar 6.
4
Scientific Integrity Requires Publishing Rebuttals and Retracting Problematic Papers.科学诚信需要发表反驳意见和撤回有问题的论文。
Stem Cell Rev Rep. 2023 Feb;19(2):568-572. doi: 10.1007/s12015-022-10465-2. Epub 2022 Oct 26.
5
Efficacy of lopinavir-ritonavir combination therapy for the treatment of hospitalized COVID-19 patients: a meta-analysis.洛匹那韦-利托那韦联合疗法治疗住院COVID-19患者的疗效：一项荟萃分析。
Future Virol. 2021 Dec. doi: 10.2217/fvl-2021-0066. Epub 2022 Jan 31.
6
A comprehensive review and update on severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and Coronavirus disease 2019 (COVID-19): what do we know now in 2021?关于严重急性呼吸综合征冠状病毒2（SARS-CoV-2）和2019冠状病毒病（COVID-19）的全面综述与更新：2021年我们现在了解了什么？
Arch Med Sci Atheroscler Dis. 2021 Apr 6;6:e5-e13. doi: 10.5114/amsad.2021.105065. eCollection 2021.
7
Emotional eating, binge eating, physical inactivity, and vespertine chronotype are negative predictors of dietary practices during COVID-19 social isolation: A cross-sectional study.情绪性进食、暴食、身体活动不足和黄昏型昼夜节律是 COVID-19 社交隔离期间饮食行为的负面预测因素：一项横断面研究。
Nutrition. 2021 Oct;90:111223. doi: 10.1016/j.nut.2021.111223. Epub 2021 Mar 9.
8
Rapid Identification of Druggable Targets and the Power of the PHENotype SIMulator for Effective Drug Repurposing in COVID-19.快速鉴定可成药靶点以及PHENotype模拟器在COVID-19有效药物再利用中的作用
Res Sq. 2021 Apr 14:rs.3.rs-287183. doi: 10.21203/rs.3.rs-287183/v1.
9
French Public Familiarity and Attitudes toward Clinical Research during the COVID-19 Pandemic.法国民众在新冠疫情期间对临床研究的认知和态度。
Int J Environ Res Public Health. 2021 Mar 5;18(5):2611. doi: 10.3390/ijerph18052611.
10
Cyber harassment of female scientists will not be the new norm.对女科学家的网络骚扰不会成为新常态。
Lancet Infect Dis. 2021 Apr;21(4):457-458. doi: 10.1016/S1473-3099(20)30944-0. Epub 2020 Dec 24.
本文引用的文献
1
Effect of hydroxychloroquine with or without azithromycin on the mortality of coronavirus disease 2019 (COVID-19) patients: a systematic review and meta-analysis.羟氯喹联合或不联合阿奇霉素对 COVID-19 患者死亡率的影响：系统评价和荟萃分析。
Clin Microbiol Infect. 2021 Jan;27(1):19-27. doi: 10.1016/j.cmi.2020.08.022. Epub 2020 Aug 26.
2
Death threats after a trial on chloroquine for COVID-19.一项关于氯喹治疗新冠肺炎的试验后出现死亡威胁。
Lancet Infect Dis. 2020 Jun;20(6):661. doi: 10.1016/S1473-3099(20)30383-2.
Zotero 插件